ALLO-ASC-CD

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	2

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03183661 (ClinicalTrials.gov)	November 16, 2016	8/6/2017	A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial	Follow-up Study to Evaluate the Safety of ALLO-ASC-CDin the Subjects With Crohn´s Disease(ALLO-ASC-C ...	Crohn Disease	Biological: ALLO-ASC-CD	Anterogen Co., Ltd.	NULL	Enrolling by invitation	18 Years	65 Years	All	9	N/A	NULL
2	NCT02580617 (ClinicalTrials.gov)	April 2015	15/10/2015	A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease	A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subj ...	Crohn's Disease	Biological: ALLO-ASC	Anterogen Co., Ltd.	NULL	Recruiting	18 Years	65 Years	All	9	Phase 1	Korea, Republic of

First Previous1Next Last